Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05855239

Quantification of Hepatic Steatosis With Different Ultrasound Frequency

Quantification of Hepatic Steatosis in Patients With Fatty Liver Disease Using Attenuation Imaging With Different Ultrasound Frequency

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Jong Keon Jang · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The objective of this study is: (1) to compare the feasibility (technical successes rate and reliability) in measuring attenuation coefficient between two different frequencies (3MHz, 4MHz) of ultrasound beam; (2) to evaluate and compare the diagnostic performance of attenuation coefficient for steatosis using two different frequencies (3MHz, 4MHz) of ultrasound beam by comparison with the pathologic results acquired by liver biopsy or surgery.

Detailed description

Investigators measure the distance between the skin and liver capsule on B-mod images. Investigators place a region of interest (ROI) avoiding reverberation artifacts and acquire attenuation coefficient for five times. For participants who require a liver biopsy, investigators try to target the same area in the liver, where ROI was placed. Investigators evaluate hepatic steatosis, lobular inflammation, and fibrosis of tissue of the liver using a scoring system suggested by Nonalcoholic Steatohepatitis Clinical Research Network.

Conditions

Timeline

Start date
2023-06-08
Primary completion
2024-06-30
Completion
2024-12-31
First posted
2023-05-11
Last updated
2024-08-06

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05855239. Inclusion in this directory is not an endorsement.